CVS Health (CVS) vs Guardian Pharmacy Services (GRDN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Guardian Pharmacy Services (GRDN) has outperformed CVS Health (CVS) over the past year, gaining 65.5% versus a gain of 3.6%. CVS Health is the larger company by market cap ($103.43 billion vs $2.97 billion), about 34.8 times the size, while Guardian Pharmacy Services is growing revenue faster (+17.9% vs +7.8%). On valuation, CVS Health trades at a lower forward P/E (9.3x vs 31.3x for Guardian Pharmacy Services).
CVS Health pays a dividend yielding 3.29%, while Guardian Pharmacy Services does not currently pay one. Guardian Pharmacy Services converts more of its revenue into profit, with a net margin of 3.4% versus 0.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVS | GRDN |
|---|---|---|
| Share price | $80.84 | $46.94 |
| Market cap | $103.43B | $2.97B |
| 1-day change | +1.00% | +0.58% |
| YTD return | +1.86% | +56.00% |
| 1-year return | +3.60% | +65.51% |
| 5-year return | -11.67% | — |
| P/E ratio (TTM) | 9.39 | 40.12 |
| Forward P/E | 9.29 | 31.26 |
| EPS (TTM) | $8.61 | $1.17 |
| Dividend yield | 3.29% | 0.00% |
| Annual dividend | $2.66 | $0.00 |
| Revenue (latest FY) | $402.07B | $1.45B |
| Revenue growth (YoY) | +7.85% | +17.93% |
| Net income (latest FY) | $1.77B | $49.22M |
| Gross margin | 44.99% | 20.21% |
| Operating margin | 1.16% | 5.02% |
| Net margin | 0.44% | 3.40% |
| 52-week high | $110.68 | $50.85 |
| 52-week low | $69.51 | $26.34 |
| Distance from 52-week high | -26.96% | -7.69% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +35.22% | +6.82% |
| Average volume | 9.53M | 547.39K |
| Shares outstanding | 1.28B | 63.32M |
| Employees | 219,000 | 3,600 |
| Sector | Consumer Staples | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores | Retail-Drug Stores and Proprietary Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CVS Health is about 34.8 times larger than Guardian Pharmacy Services by market value ($103.43B vs $2.97B).
- GRDN has outperformed CVS by 61.9 percentage points over the past year.
- Guardian Pharmacy Services trades at a higher earnings multiple (40.1x vs 9.4x trailing P/E).
- CVS Health offers a meaningfully higher dividend yield (3.29% vs 0.00%).
- Guardian Pharmacy Services grew revenue faster in its latest fiscal year (+17.93% vs +7.85%).
About CVS Health
CVS stock →CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 219,000 employees
About Guardian Pharmacy Services
GRDN stock →Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 3,600 employees
CVS vs GRDN FAQ
Which is bigger, CVS Health or Guardian Pharmacy Services?
CVS Health (CVS) is larger, with a market capitalization of $103.43B compared with $2.97B for Guardian Pharmacy Services (GRDN).
Which stock has performed better over the past year, CVS or GRDN?
GRDN returned +65.51% over the past 12 months, compared with +3.60% for CVS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CVS or GRDN?
CVS has the lower trailing P/E at 9.4, versus 40.1 for GRDN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CVS Health or Guardian Pharmacy Services?
CVS Health pays a dividend yielding 3.29%, while Guardian Pharmacy Services does not currently pay a regular dividend.
Are CVS Health and Guardian Pharmacy Services in the same industry?
Yes. Both are classified in the Retail-Drug Stores and Proprietary Stores industry within the Consumer Staples sector.